Ergomed plc Results of 2022 Annual General Meeting (4909O)
10 Junio 2022 - 05:21AM
UK Regulatory
TIDMERGO
RNS Number : 4909O
Ergomed plc
10 June 2022
PRESS RELEASE
Results of 2022 Annual General Meeting
Guildford, 10 June 2022: Ergomed plc (AIM: ERGO) ("Ergomed" or
the "Company"), a company focused on providing specialised services
to the pharmaceutical industry, announces the results of voting on
the resolutions put to shareholders at its Annual General Meeting
("AGM") held earlier today. All Resolutions were duly passed.
Details of the voting by way of a poll at the AGM in respect of
each resolution are shown in the table below:
Resolution R esolution Votes for Votes Abstentions
number against
1 Accounts 40,070,518 0 1,492,956
-------------------------- ----------- ---------- ------------
2 Reappoint auditor 41,493,555 69,125 794
-------------------------- ----------- ---------- ------------
3 Reappoint John Dawson 41,454,634 107,895 945
-------------------------- ----------- ---------- ------------
4 Reappoint Mark Enyedy 34,200,041 7,362,488 945
-------------------------- ----------- ---------- ------------
5 Reappoint Michael Spiteri 32,439,508 9,123,278 688
-------------------------- ----------- ---------- ------------
6 Allot securities 39,399,013 2,163,803 658
-------------------------- ----------- ---------- ------------
7 Pre-emption rights 39,808,724 1,754,493 257
-------------------------- ----------- ---------- ------------
8 Pre-emption rights 39,699,675 1,863,542 257
-------------------------- ----------- ---------- ------------
Amendment to Articles of
9 Association 41,563,066 0 408
-------------------------- ----------- ---------- ------------
The full text of all resolutions can be found in the Notice of
Annual General Meeting on the Company's website
www.ergomedplc.com
Ergomed's Board engage with the Company's shareholders and other
stakeholders to understand their views. Whilst all resolutions were
passed, shareholders representing over 20% of votes cast voted
against Resolution 5 and the Board will re-engage with them to
better understand their position.
ENDS
Enquiries :
Ergomed plc Tel: +44 (0) 1483 402 975
Dr Miroslav Reljanović (Executive Chairman)
Richard Barfield (Chief Financial Officer)
Keith Byrne (Senior Vice-President, Capital Markets &
Strategy)
Numis Tel: +44 (0) 20 7260 1000
Freddie Barnfield / Euan Brown (Nominated Adviser)
James Black (Broker)
Peel Hunt LLP Tel: +44 (0) 20 7418 8900
James Steel / Dr Christopher Golden
Consilium Strategic Communications Tel: +44 (0) 20 3709 5700
Chris Gardner / Matthew Neal ergomed@consilium-comms.com
Angela Gray
About Ergomed plc
Ergomed provides specialist services to the pharmaceutical
industry spanning all phases of clinical development, post-approval
pharmacovigilance and medical information. Ergomed's fast-growing
services business includes an industry-leading suite of specialist
pharmacovigilance (PV) solutions, integrated under the
PrimeVigilance brand, a full range of high-quality clinical
research and trial management services under the Ergomed brand
(CRO) and mission-critical regulatory compliance and consulting
services under the ADAMAS brand. For further information, visit:
http://ergomedplc.com .
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
RAGEAEKEFFPAEFA
(END) Dow Jones Newswires
June 10, 2022 06:21 ET (10:21 GMT)
Ergomed (LSE:ERGO)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024
Ergomed (LSE:ERGO)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024